Business · 15/07/2020Updated: 10/17/2026 · 1 min read
FDA Declines to Designate Coccidioidomycosis as Tropical Disease for Priority Review Voucher
Summary
The FDA has decided not to add coccidioidomycosis to the list of tropical diseases eligible for a priority review voucher, citing the potential market for preventive products in developed countries.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →